News

There are only a few good reasons why a child might be seen in a Hudson Institute lab.…  Read more

Tiny fragments of RNA, once thought to be molecular waste, could spawn a new class of treatments for debilitating autoimmune and auto-inflammatory diseases.…  Read more

Many childhood cancers are so rare that researchers simply don’t have precise models to study them. Our renewable patient-derived tumour models change that. …  Read more

There is a paradox in the funding of Hudson Institute’s newborn health research. Rather than curing existing diseases, the success of this research is seen in the absence of illness.…  Read more

With the 2026 flu season already here, understanding who is most at risk, how vaccination works, and what steps you can take to protect yourself may help reduce its impact.…  Read more

Researchers were aiming to find a genetic solution to a rare and devastating disease but were not able to identify one. However, in the process they identified a crucial factor in one of life’s most essential processes.…  Read more

Australia’s role in international science leadership has been reconfirmed with the appointment of Hudson Institute Hudson Institute Director and CEO, Professor Elizabeth Hartland AM FAHMS, to the Human Frontier Science Program’s Council of Scientists.…  Read more

A Hudson Institute research project aimed at reducing the recurrence of ovarian cancer has been awarded a significant grant by the Ovarian Cancer Research Foundation (OCRF).…  Read more

Not content with drawing attention to the condition and improving its treatment, the people behind Hudson Institute’s Primary Aldosteronism Centre of Excellence (PACE) have now identified a faster, gentler way of identifying its cause.…  Read more

As Australia approaches another flu season, the nation’s peak medical research funding body has recognised a Hudson Institute researcher for her pioneering work on influenza.…  Read more